• Mixed moods prevail in the Asian markets today. Nikkei lost 0.42%, Kospi rose 0.07% and Hang Seng gained 0.38%. S&P/ASX 200 dropped 0.12%. Dax futures point to a lower opening of the European session
• US reported a record daily high of 185,000 new COVID-19 cases on Thursday
• US Senate Democratic Minority Leader Chuck Schumer said Republican Majority Leader Mitch McConnell had agreed to revive stimulus talks as COVID-19 cases continue to rise.
• US Treasury Secretary Steven Mnuchin said on Thursday he will not extend several emergency loan programs set up with the Federal Reserve to support the economy ravaged by the COVID-19 crisis (these programs will expire on December, 31st). Mnuchin added that he is requesting that the Fed return to the Treasury the unused CARES funds appropriated by Congress for the operation of the programs.
• People's Bank of China left its key interest rates steady for the seventh straight month at its November fixing. The one-year loan prime rate (LPR) was left unchanged at 3.85% after two cuts this year, while the five-year remained at 4.65%.
• Pfizer is expected to file FDA application for COVID-19 vaccine today
• Japan Prime Minister Yoshihide Suga said Thursday that Japan is on maximum alert while metropolitan Tokyo raised its alert level to the highest of four.
• Australia retail sales rose by 1.6 % month-over-month in October, well above market consensus of a 0.3 % rise and after a 1.1 % fall a month earlier, a preliminary reading showed.
• AUD and NZD are leaders among major currencies while USD and JPY lag the most
Yesterday 647 719 000 new coronavirus cases were reported which is the second highest number since the pandemic began. Source: worldometers, XTBThe content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
